Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06189807 · ClinicalTrials.gov registry record · NA
Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)
A NA study of Chronic Kidney Diseases and CKD, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06189807: Active NA study of Chronic Kidney Diseases and CKD, sponsored by University of Michigan.
NCT06189807 is a NA study of Chronic Kidney Diseases and CKD that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 70 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06189807, a NA study of Chronic Kidney Diseases and CKD, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will assess the efficacy of a pregnancy and contraception education decision aid (DA) for patients with chronic kidney disease to support decisions about reproductive health, and will assess feasibility and acceptability of the intervention to inform future Research Project Grant (R01) level studies.
Primary Outcome
This is a 10-item survey that participants answer not at all (1) to a great deal (5). PrepDM is scored on a 0-100 scale, where higher score indicates better preparation for decision making. A score of \>75 is a clinically significant cut off that indicates participants being well prepared to make decisions after reviewing a DA.The PrepDM scale was adapted slightly to meet the needs of the target population and the developed novel decision aid.
Conditions Studied
Interventions
- BEHAVIORAL Decision aid
- OTHER Standard handout
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-02-14 |
| Est. Completion | 2026-09-25 |
| Phase | NA |
What the registry record for NCT06189807 still lists
NCT06189807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Decision aid is the first listed.
NCT06189807 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06189807 about?
NCT06189807 is a clinical study titled "Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)". This pilot study will assess the efficacy of a pregnancy and contraception education decision aid (DA) for patients with chronic kidney disease to support decisions about reproductive health, and will assess feasibility and acceptability of the intervention to inform future Research Project Grant (R...
What is the current status of trial NCT06189807?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-02-14. Estimated completion is 2026-09-25.
What conditions does trial NCT06189807 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, CKD.
What interventions are being tested in trial NCT06189807?
The interventions under investigation include: Decision aid (BEHAVIORAL), Standard handout (OTHER).
Who is sponsoring clinical trial NCT06189807?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06189807 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06189807's enrollment target sits among peer trials
70 47th of 73 higher than 26 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI